IL113606A0 - Substituted bicyclic heteroaroylguanidines, a process for their preparation their use as a medicament or a diagnostic agent and a medicament containing them - Google Patents

Substituted bicyclic heteroaroylguanidines, a process for their preparation their use as a medicament or a diagnostic agent and a medicament containing them

Info

Publication number
IL113606A0
IL113606A0 IL11360695A IL11360695A IL113606A0 IL 113606 A0 IL113606 A0 IL 113606A0 IL 11360695 A IL11360695 A IL 11360695A IL 11360695 A IL11360695 A IL 11360695A IL 113606 A0 IL113606 A0 IL 113606A0
Authority
IL
Israel
Prior art keywords
medicament
poly
preparation
diagnostic agent
substituted bicyclic
Prior art date
Application number
IL11360695A
Other languages
English (en)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IL113606A0 publication Critical patent/IL113606A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/08—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with a hetero atom directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL11360695A 1994-05-05 1995-05-03 Substituted bicyclic heteroaroylguanidines, a process for their preparation their use as a medicament or a diagnostic agent and a medicament containing them IL113606A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4415873A DE4415873A1 (de) 1994-05-05 1994-05-05 Substituierte bizyklische Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Publications (1)

Publication Number Publication Date
IL113606A0 true IL113606A0 (en) 1995-08-31

Family

ID=6517371

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11360695A IL113606A0 (en) 1994-05-05 1995-05-03 Substituted bicyclic heteroaroylguanidines, a process for their preparation their use as a medicament or a diagnostic agent and a medicament containing them

Country Status (19)

Country Link
US (1) US6093729A (fr)
EP (1) EP0682017B1 (fr)
JP (1) JP3774771B2 (fr)
KR (1) KR950032129A (fr)
CN (1) CN1117045A (fr)
AT (1) ATE183179T1 (fr)
AU (1) AU693861B2 (fr)
CA (1) CA2148666A1 (fr)
DE (2) DE4415873A1 (fr)
DK (1) DK0682017T3 (fr)
ES (1) ES2136767T3 (fr)
FI (1) FI952117A (fr)
GR (1) GR3031539T3 (fr)
HU (1) HUT72089A (fr)
IL (1) IL113606A0 (fr)
NO (1) NO304830B1 (fr)
NZ (1) NZ272058A (fr)
TW (1) TW429252B (fr)
ZA (1) ZA953588B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5627193A (en) * 1995-02-09 1997-05-06 Mitsui Toatsu Chemicals, Inc. Quinoline-4-carbonylguanidine derivatives, process for producing the same and pharmaceutical preparations containing the compounds
DE19540995A1 (de) * 1995-11-03 1997-05-07 Hoechst Ag Substituierte Sulfonimidamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19542306A1 (de) * 1995-11-14 1997-05-15 Hoechst Ag Sulfonylamino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
PL316439A1 (en) * 1995-11-20 1997-05-26 Hoechst Ag Novel substituted derivatives of benzoyloguanidine, method of obtaining them, their application in production of pharmaceutic and diagnostic agents and pharmaceutic agent as such
DE19546736A1 (de) * 1995-12-14 1997-06-19 Hoechst Ag Substituierte Chromanylsulfonyl(thio)harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Präparate
DE19548812A1 (de) * 1995-12-27 1997-07-03 Hoechst Ag Verwendung von Inhibitoren des zellulären Na·+·/H·+·-Exchangers (NHE) zur Herstellung eines Medikaments zur Atemstimulation
CA2195697A1 (fr) * 1996-02-02 1997-08-03 Masahumi Kitano Derives substitues de la guanidine, procede pour leur obtention et leurs utilisations pharmaceutiques
DE19621482A1 (de) * 1996-05-29 1997-12-04 Hoechst Ag Substituierte 1-Naphthoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19621483A1 (de) * 1996-05-29 1997-12-04 Hoechst Ag Substituierte 2-Naphthoylguanidine, Verfahren zur ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
JP3652708B2 (ja) 1997-03-06 2005-05-25 トーアエイヨー株式会社 シクロアルカ［ｂ］ピリジン−３−カルボニルグアニジン誘導体、その製造法およびそれを含有する医薬品
WO1998055475A1 (fr) * 1997-06-02 1998-12-10 Fujisawa Pharmaceutical Co., Ltd. Derives de guanidine utilises comme inhibiteurs de l'echange na+/h+ dans les cellules
CA2316944A1 (fr) 1998-02-20 1999-08-26 Mitsuru Shiraishi Derives d'aminoguanidine hydrazone, procedes de production, et leur utilisation
WO2000075115A1 (fr) 1999-06-03 2000-12-14 Takeda Chemical Industries, Ltd. Preparations s'administrant par voie nasale
JP5030587B2 (ja) * 2003-06-26 2012-09-19 バイオトロン・リミテッド 抗ウイルスアシルグアニジン化合物および方法
CN104370813A (zh) * 2014-10-22 2015-02-25 上海大学 异喹啉-6-甲醛的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3780027A (en) * 1970-04-29 1973-12-18 Merck & Co Inc Anthranilic acid derivatives
DE3929582A1 (de) * 1989-09-06 1991-03-07 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
CZ284456B6 (cs) * 1992-02-15 1998-12-16 Hoechst Aktiengesellschaft Aminosubstituované benzoylguanidiny, způsob jejich přípravy, jejich použití jako léčiv a léčivo, které je obsahuje
DE59307360D1 (de) * 1992-02-15 1997-10-23 Hoechst Ag Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
EP0556674B1 (fr) * 1992-02-15 1996-06-19 Hoechst Aktiengesellschaft Benzoylguanidines 3,5-substitués avec une activité antiarrhythmique et une activité inhibitrice de la prolifération des cellules
ES2152938T3 (es) * 1992-09-28 2001-02-16 Hoechst Ag 1(2h)-isoquinolinas sustituidas antiarritmicas y cardioprotectoras, procedimiento para su produccion, medicamento que las contiene y su uso para la produccion de un medicamento para combatir fallos cardiacos.

Also Published As

Publication number Publication date
HUT72089A (en) 1996-03-28
CA2148666A1 (fr) 1995-11-06
CN1117045A (zh) 1996-02-21
JP3774771B2 (ja) 2006-05-17
NO304830B1 (no) 1999-02-22
FI952117A (fi) 1995-11-06
ZA953588B (en) 1996-06-16
DE4415873A1 (de) 1995-11-09
GR3031539T3 (en) 2000-01-31
AU693861B2 (en) 1998-07-09
NO951736D0 (no) 1995-05-04
AU1786195A (en) 1995-11-16
US6093729A (en) 2000-07-25
NO951736L (no) 1995-11-06
DK0682017T3 (da) 1999-12-13
NZ272058A (en) 1996-02-27
FI952117A0 (fi) 1995-05-03
EP0682017A1 (fr) 1995-11-15
ATE183179T1 (de) 1999-08-15
EP0682017B1 (fr) 1999-08-11
KR950032129A (ko) 1995-12-20
ES2136767T3 (es) 1999-12-01
JPH0841028A (ja) 1996-02-13
DE59506564D1 (de) 1999-09-16
TW429252B (en) 2001-04-11

Similar Documents

Publication Publication Date Title
ZA953588B (en) Substituted bicyclic heteroaroylguanidines a process for their preparation their use as a medicament or a diagnostic agent and a medicament containing them
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
MX9100062A (es) Composiciones en polvo para revestimiento para la fabricacion de las mismas
PT97866A (pt) Processo para a preparacao de uma composicao de um fluxo vitreo
SE8902326D0 (sv) Karboxamidfoereningar, foerfaranden foer framstaellning av dem och farmceutiska kompositioner som innehaaller dem
FI954304A (fi) Uudet bentsopyraanijohdannaiset, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
FI920023A0 (fi) Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
OA08501A (en) Zwitterionic bicyclic compounds and their salts, solvates, hydrates and esters.
MX9301298A (es) Seudopeptidos, procedimiento para su preparacion y composicion farmaceutica que los contiene.
IL117150A (en) Substituted benzenesulfonylureas and - thioureas processes for their preparation their use in the preparation of medicaments and pharmaceutical compositions containing them
NZ238795A (en) N-((bis(phenyl)methylthio)alkyl)benzene alkylamine derivatives; their preparation and pharmaceutical compositions
EP0279633A3 (en) Anticonvulsant agents
ZA918282B (en) Derivatives of(p.substituted phenyl)oxybutane amines,their processes of production and the pharmaceutical compositions containing them
ITRM920039A0 (it) Uso dell'acido ialuronico lubrificante di protesi oculari.
PT97052A (pt) Processo para a preparacao de composicoes farmaceuticas contendo bambuterol, apropriadas para diminuir o teor de lipidos no sangue
DK160807C (da) Immunomodulerende laegemiddel af biologisk oprindelse samt fremgangsmaade til fremstilling deraf
TW228524B (fr)
ES2108022T3 (es) Un nuevo antibiotico, balimicina, un procedimiento para su produccion y su utilizacion como producto farmaceutico.
IL115235A0 (en) Bicyclic oxazole and thiazole substituted ethers and thioethers their preparation and pharmaceutical compositions containing them
FI905664A (fi) Glutarsyraderivat och deras framstaellningsfoerfaranden.
ES8604160A1 (es) Procedimiento para la obtencion de iminosulfonamidas
DE3362348D1 (en) Pyridine derivatives, their preparation and their application
IT8121635A1 (it) Procedimento di produzione di derivati di esteri malonici e prodotti ottenuti con attivita' antiprotozoaria, antimicotica e antibatterica
BG50741A1 (en) Antimicrobial preparation
CS394590A3 (en) Material for sliding surfaces, particularly of bearings